Print this article
- 03/07/2025

PROCOS at DCAT Week 2025: Celebrating 80 Years of Excellence and Future Growth

Chimica Oggi-Chemistry Today

 

DCAT Week has long been a cornerstone of strategic engagement for PROCOS. For over 30 years, we have actively participated in this global business development forum, leveraging it to strengthen partnerships, expand collaborations, and contribute to key discussions shaping the pharmaceutical industry. This year, we are proud to take an even more active role as a speaker at the DCAT Announcement Forum, where we will share insights into our latest developments and future vision. 

As we approach our 80th anniversary in 2025, this milestone underscores PROCOS’ remarkable journey. Since joining the CBC Group in 2006, we have achieved significant growth, with a strong focus on innovation, sustainability, and operational excellence. To mark this anniversary, we will launch a series of initiatives aimed at reinforcing connections with employees and partners while highlighting our expertise and legacy in the API industry. 

A key pillar of our continued expansion is the state-of-the-art R11 manufacturing facility. With its building shell complete and equipment installation underway, R11 will feature 20 reactors across four multi-purpose production lines, offering capacities from 1,000 to 6,000 liters. This expansion adds 73 cubic meters to our existing production capacity, addressing the increasing global demand for high-value, complex small molecules drug substances, particularly in clinical development. 

Scheduled for full qualification in 2025, the R11 facility will boost PROCOS’ overall manufacturing capacity by 25

Understanding the unique challenges of smaller biotech companies—where evolving funding landscapes and shifting priorities create dynamic project needs, PROCOS remains committed to flexibility and adaptability. Our ability to scale production efficiently and adjust timelines in response to evolving requirements strengthens our role as a reliable, long-term partner. 

Adding to this exciting year, PROCOS is honored to be a finalist for the 2025 CDMO Leadership Awards in the Small Molecule API International category. This recognition underscores our commitment to excellence and customer-centric solutions in API development and manufacturing. The winners will be announced at an exclusive ceremony at The POOL in midtown Manhattan on March 19, 2025. 

As we look ahead, PROCOS is poised for transformative growth. With the launch of the R11 facility, continued investment in cutting-edge technology, and an unwavering dedication to talent development, we remain at the forefront of API manufacturing, ready to meet the evolving needs of our global partners. 

 

Procos – DCAT Week 2025